187 related articles for article (PubMed ID: 34276155)
1. Extrahepatic Malignancies and Liver Transplantation: Current Status.
Choudhary NS; Saigal S; Saraf N; Soin AS
J Clin Exp Hepatol; 2021; 11(4):494-500. PubMed ID: 34276155
[TBL] [Abstract][Full Text] [Related]
2. Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation.
Park GC; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Yoon YI; Cho HD; Kwon JH; Chung YK; Kang SH; Choi JU; Jung IJ; Lee SG
J Korean Med Sci; 2020 Mar; 35(11):e69. PubMed ID: 32193900
[TBL] [Abstract][Full Text] [Related]
3. Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients: report of the studies of pediatric liver transplantation experience.
Narkewicz MR; Green M; Dunn S; Millis M; McDiarmid S; Mazariegos G; Anand R; Yin W;
Liver Transpl; 2013 Jul; 19(7):730-40. PubMed ID: 23696264
[TBL] [Abstract][Full Text] [Related]
4. Incidence, risk factors and outcomes of de novo malignancies post liver transplantation.
Mukthinuthalapati PK; Gotur R; Ghabril M
World J Hepatol; 2016 Apr; 8(12):533-44. PubMed ID: 27134701
[TBL] [Abstract][Full Text] [Related]
5. High rates of de novo malignancy compromise post-heart transplantation survival.
Giuliano K; Canner JK; Etchill E; Suarez-Pierre A; Choi CW; Higgins RSD; Hsu S; Sharma K; Kilic A
J Card Surg; 2021 Apr; 36(4):1401-1410. PubMed ID: 33567114
[TBL] [Abstract][Full Text] [Related]
6. De novo malignancies after liver transplantation: a single-center experience.
Hegab B; Khalaf H; Allam N; Azzam A; Al Khail FA; Al-hamoudi W; Kamel Y; Al Bahili H; Al Sofayan M; Al-Sebayel M
Ann Saudi Med; 2012; 32(4):355-8. PubMed ID: 22705604
[TBL] [Abstract][Full Text] [Related]
7. De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference.
Colmenero J; Tabrizian P; Bhangui P; Pinato DJ; Rodríguez-Perálvarez ML; Sapisochin G; Bhoori S; Pascual S; Senzolo M; Al-Adra D; Herrero JI; Petrowsky H; Dawson LA; Hosni A; Kutzke JL; Gastaca M; Watt KD
Transplantation; 2022 Jan; 106(1):e30-e45. PubMed ID: 34905760
[TBL] [Abstract][Full Text] [Related]
8. De novo malignancies after liver transplantation: a major cause of late death.
Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
[TBL] [Abstract][Full Text] [Related]
9. Survival after the diagnosis of de novo malignancy in liver transplant recipients.
Taborelli M; Piselli P; Ettorre GM; Baccarani U; Burra P; Lauro A; Galatioto L; Rendina M; Shalaby S; Petrara R; Nudo F; Toti L; Fantola G; Cimaglia C; Agresta A; Vennarecci G; Pinna AD; Gruttadauria S; Risaliti A; Di Leo A; Rossi M; Tisone G; Zamboni F; Serraino D;
Int J Cancer; 2019 Jan; 144(2):232-239. PubMed ID: 30091809
[TBL] [Abstract][Full Text] [Related]
10. Chronological alterations in de novo malignancies after living-donor liver transplantation: A cohort study of 1781 recipients using annual comparisons of standardized incidence ratios.
Tajima T; Hata K; Tanaka K; Iyama N; Kusakabe J; Kageyama S; Ogawa E; Okamoto T; Haga H; Uemoto S; Hatano E
J Hepatobiliary Pancreat Sci; 2024 Jun; ():. PubMed ID: 38845404
[TBL] [Abstract][Full Text] [Related]
11. Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.
Sérée O; Altieri M; Guillaume E; De Mil R; Lobbedez T; Robinson P; Segol P; Salamé E; Abergel A; Boillot O; Conti F; Chazouillères O; Debette-Gratien M; Debray D; Hery G; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Jacquemin E; Kamar N; Latournerie M; Lebray P; Leroy V; Mazzola A; Neau-Cransac M; Pageaux GP; Radenne S; Saliba F; Samuel D; Vanlemmens C; Woehl-Jaegle ML; Launoy G; Dumortier J
Liver Transpl; 2018 Oct; 24(10):1425-1436. PubMed ID: 30021061
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States.
Quinlan SC; Pfeiffer RM; Morton LM; Engels EA
Am J Hematol; 2011 Feb; 86(2):206-9. PubMed ID: 21264909
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study.
Shalaby S; Taborelli M; Zanetto A; Ferrarese A; D'Arcangelo F; Gambato M; Senzolo M; Russo FP; Germani G; Boccagni P; Ettorre GM; Baccarani U; Lauro A; Galatioto L; Rendina M; Petrara R; De Rossi A; Nudo F; Toti L; Fantola G; Vennarecci G; Risaliti A; Pinna AD; Gruttadauria S; Di Leo A; Rossi M; Tisone G; Zamboni F; Cillo U; Piselli P; Serraino D; Burra P;
Transpl Int; 2021 Apr; 34(4):743-753. PubMed ID: 33492715
[TBL] [Abstract][Full Text] [Related]
14. Roles of Epstein-Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation.
Chen HS; Ho MC; Hu RH; Wu JF; Chen HL; Ni YH; Hsu HY; Jeng YM; Chang MH
J Formos Med Assoc; 2019 Sep; 118(9):1362-1368. PubMed ID: 30612881
[TBL] [Abstract][Full Text] [Related]
15. The incidence and risk factors of de novo skin cancer in the liver transplant recipients.
Modaresi Esfeh J; Hanouneh IA; Dalal D; Tabba A; Lopez R; Pagadala M; Eghtesad B; Zein NN
Int J Organ Transplant Med; 2012; 3(4):157-63. PubMed ID: 25013641
[TBL] [Abstract][Full Text] [Related]
16. The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience.
Peters AC; Akinwumi MS; Cervera C; Mabilangan C; Ghosh S; Lai R; Iafolla M; Doucette K; Preiksaitis JK
Transplantation; 2018 Sep; 102(9):1553-1562. PubMed ID: 29485513
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies.
Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
Ann Hematol; 2019 Sep; 98(9):2163-2177. PubMed ID: 31243569
[TBL] [Abstract][Full Text] [Related]
18. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
19. A Scheduled Program of Molecular Screening for Epstein-Barr Virus Decreases the Incidence of Post-transplantation Lymphoproliferative Disease in Pediatric Liver Transplantation.
Soriano-López DP; Alcántar-Fierros JM; Hernández-Plata JA; González-Jorge AL; Velázquez-Ramos S; Flores-Hernández MA; Fuentes V; Castañeda P; Nieto J; Sánchez JL; López B; Valencia-Mayoral P; Varela-Fascinetto G
Transplant Proc; 2016 Mar; 48(2):654-7. PubMed ID: 27110023
[TBL] [Abstract][Full Text] [Related]
20. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience.
Jain A; Nalesnik M; Reyes J; Pokharna R; Mazariegos G; Green M; Eghtesad B; Marsh W; Cacciarelli T; Fontes P; Abu-Elmagd K; Sindhi R; Demetris J; Fung J
Ann Surg; 2002 Oct; 236(4):429-36; discussion 436-7. PubMed ID: 12368671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
